Outcomes of early first trimester medical termination of pregnancy: retrospective study

Authors

  • Prabhalya S. Department of Obstetrics and Gynecology, Shri Kumaran, a Multispeciality Hospital, Chennai, Tamil Nadu, India
  • Annith Kumar V. M. Department of Obstetrics and Gynecology, Shri Kumaran, a Multispeciality Hospital, Chennai, Tamil Nadu, India
  • Umaiyal Murugesan Department of Obstetrics and Gynecology, Shri Kumaran, a Multispeciality Hospital, Chennai, Tamil Nadu, India
  • Prasiddha S. Department of Obstetrics and Gynecology, Shri Kumaran, a Multispeciality Hospital, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20231918

Keywords:

Abortion, Gestation, Misoprostol, Mifepristone

Abstract

Background: Unsafe abortion is a major public health problem. Globally, 20 million unsafe abortions occur each year, accounting for 13% of all maternal deaths. According to WHO, 56% of abortions in developing countries are still unsafe even though medical abortion methods have been used for over a decade. The main objective of the present study is to compare the efficacy, acceptability, side effects and factors affecting the outcome of early medical abortion with oral and vaginal misoprostol after oral mifepristone in inducing early medical abortion up to 8 weeks of gestation.

Methods: A one-year retrospective, observational study was conducted. A total of 82 post-MTP patients were included in this study. Data retrieved from the hospital database was tabulated and analysed.

Results: The majority of women who underwent the procedure fell into the age group of 26-30 years (32.9%), on observing the parity of the mothers a whopping 82.9% were multiparous. The finished family (41.5%) was the most common reason for MTP. The incidence of RPOC in the study group was 31.7%. About 26.8% of the patients did not come back for follow-up.

Conclusions: The majority of women who underwent the procedure fell into the age group of 26-30 years (32.9%), on observing the parity of the mothers a whopping 82.9% were multiparous. The finished family (41.5%) was the most common reason for MTP. The incidence of RPOC in the study group was 31.7%. About 26.8% of the patients did not come back for follow-up.

Metrics

Metrics Loading ...

References

India Is the World’s Most Populous Country: What It Means”. Available at: thediplomat.com. Accessed 13 March 2023.

MOHFW. Available from: https://main.mohfw.gov.in/sites/default/files/Final%20AR%202020-21.pdf.

Induced Abortion in India: A Review of Literature,’ by R.Kalyanwala, V. Zavier, and N.Jejeebhoy, published in the Journal of Reproductive Health and Medicine in 2015.

Pawde AA, Ambadkar A, Chauhan AR. A study of incomplete abortion following medical method of abortion (MMA). J Obstet Gynecol India. 2016;66:239-43.

Complications of Miscarriage,’ by the American College of Obstetricians and Gynecologists (ACOG). The ACOG provides information on RPOC and how it can cause complications such as infertility.

Shivakumar BC, Vishvanath D, Srivastava PC. A profile of abortion cases in a Tertiary Care Hospital. J Indian Acad Forensic Med. 2011;33(1):33-8.

Agarwal K, et al., published in the Journal of Health, Population, and Nutrition in. Barriers to contraceptiveuse in ruralIndia;2019.

Singh K, et al., published in the Journal of Family and Reproductive Health in. Contraceptive knowledge, attitudes, and practices in urban and ruralIndia;2014.

World Health Organization. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008, 6th ed. Geneva: WHO; 2011.

Ministry of Health and Family Welfare, Government of India. National health Profile 2018. New Delhi: Central Bureau of Health Intelligence.

Holla R, Kanchan T, Unnikrishnan B, Kotian MS, Kumar N, Thapar R, et al. Profile of women seeking medical termination of pregnancy in South India. Int J Gynecol Obstet. 2014;125(3):253-5.

Carlsson I, Breding K, Larsson PG. Complications related to induced abortion: a combined retrospective and longitudinal follow-up study. BMC Womens Health. 2018;18(1):158.

Haimov-Kochman R, Arbel R, Sciaky-Tamir Y, Brzezinski A, Laufer N, Yagel S. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol. Acta Obstet Gynecol Scand. 2007;86(4):462-6.

Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG. 2002;109(11):1281-9.

Hamel CC, Vart P, Vandenbussche FP, Braat DD, Snijders MP, Coppus SF. Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model. Hu Reproduct. 2022;37(5):936-46.

Nath AG, Kumar A. On efficacy and acceptability of early medical abortion by mifepristone with oral or vaginal misoprostol. J Evol Med Dent Sci. 2017;6(66):4757-61.

Creinin MD, Grossman DA. Medical management of first-trimester abortion. Contracep. 2014;89(3):148-61.

Downloads

Published

2023-06-28

How to Cite

S., P., V. M., A. K., Murugesan, U., & S., P. (2023). Outcomes of early first trimester medical termination of pregnancy: retrospective study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 12(7), 2109–2112. https://doi.org/10.18203/2320-1770.ijrcog20231918

Issue

Section

Original Research Articles